Related Experiment Video
Updated: Mar 8, 2026

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
Polycomb complexes PRC1 and their function in hematopoiesis
Miguel Vidal1, Katarzina Starowicz1
1Department of Cellular and Molecular Biology, Centro de Investigaciones Biológicas, Madrid, Spain.
Insights
Polycomb repressive complex 1 (PRC1) proteins are crucial for maintaining cell identity during blood cell development. New research explores their function in normal hematopoiesis and blood cancers.
Area of Science:
- Molecular Biology
- Epigenetics
- Hematology
Background:
- Hematopoiesis is a well-studied blood cell production pathway.
- Mutations in gene regulators, including chromatin regulators like Polycomb group (PcG) proteins, are linked to hematological diseases.
- PcG proteins form Polycomb repressive complexes (PRCs), essential for gene silencing and cell identity maintenance during differentiation.
Purpose of the Study:
- To review recent evidence on Polycomb repressive complex 1 (PRC1) complexes.
- To discuss PRC1 architecture, recruitment mechanisms, and transcriptional control.
- To examine hematopoietic PRC1 gain- and loss-of-function mouse models in normal hematopoiesis and hematological malignancies.
Main Methods:
- Literature review focusing on PRC1 complexes.
- Analysis of established and emerging findings on PRC1 activities in differentiated cells.
- Discussion of genetic analyses using hematopoietic PRC1 mouse models.
Main Results:
- PRC1 complexes function as histone H2A E3 ubiquitin ligases.
- New findings are refining established conceptions of PRC1 activities, particularly in differentiated cells.
- Genetic analyses in mouse models offer critical insights into PRC1 roles in hematopoiesis and leukemia.
Conclusions:
- PRC1 complexes play a vital role in regulating gene expression during hematopoiesis.
- Understanding PRC1 mechanisms is crucial for deciphering the molecular basis of hematological diseases.
- Hematopoietic PRC1 mouse models are powerful tools for validating molecular mechanisms in normal and malignant hematopoiesis.
Abstract:
Hematopoiesis, the process by which blood cells are continuously produced, is one of the best studied differentiation pathways. Hematological diseases are associated with reiterated mutations in genes encoding important gene expression regulators, including chromatin regulators. Among them, the Polycomb group (PcG) of proteins is an essential system of gene silencing involved in the maintenance of cell identities during differentiation. PcG proteins assemble into two major types of Polycomb repressive complexes (PRCs) endowed with distinct histone-tail-modifying activities. PRC1 complexes are histone H2A E3 ubiquitin ligases and PRC2 trimethylates histone H3. Established conceptions about their activities, mostly derived from work in embryonic stem cells, are being modified by new findings in differentiated cells. Here, we focus on PRC1 complexes, reviewing recent evidence on their intricate architecture, the diverse mechanisms of their recruitment to targets, and the different ways in which they engage in transcriptional control. We also discuss hematopoietic PRC1 gain- and loss-of-function mouse strains, including those that model leukemic and lymphoma diseases, in the belief that these genetic analyses provide the ultimate test for molecular mechanisms driving normal hematopoiesis and hematological malignancies.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Hematopoiesis
Multipotency of Hematopoietic Stem Cells
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Lineage Commitment

